Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.

Merck's Next Phase of Patient Centricity in R&D

  • Broadcast in Science
Pharma Talk Radio

Pharma Talk Radio

Featured Host
×  

Follow This Show

If you liked this show, you should follow Pharma Talk Radio.
h:548881
s:11578535
archived
Play
  • Host

In this podcast, hear a session from the 2019 Patients as Partners EU meeting where Merck's Vanessa Pott presented a case study on Innovative Medicines Development and Merck KGaA's next phase of Patient Centricity in R&D. 

The 4th annual Patients as Partners EU conference will take place on January 27-28, 2020 in London, UK.

To learn more about the program and patient centricity in R&D, visit theconferenceforum.org.

Facebook comments

Available when logged-in to Facebook and if Targeting Cookies are enabled